PI
XLRN

PEAK6 Investments’s Acceleron Pharma XLRN Stock Holding History

PEAK6 Investments’s Portfolio XLRN Stock Details XLRN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-30,300
Closed -$5.21M – 6133
2021
Q3 		$5.21M Sell
30,300
-128,000
-81% -$16.7M 0.01% 1129
2021
Q2 		$19.9M Buy
158,300
+9,300
+6% +$1.17M 0.05% 372
2021
Q1 		$20.2M Buy
149,000
+146,800
+6,673% +$19M 0.05% 350
2020
Q4 		$281K Sell
2,200
-10,100
-82% -$1.18M ﹤0.01% 3541
2020
Q3 		$1.38M Buy
+12,300
New +$1.22M ﹤0.01% 1992

PEAK6 Investments's XLRN Position: Q4 2021 in Review

PEAK6 Investments sold out of Acceleron Pharma (XLRN) in Q4 2021, closing a stake of 3,581 shares — an estimated $616K sold.

PEAK6 Investments first reported a position in XLRN in Q3 2020 and held it in 5 quarters. The position peaked at $787K in Q1 2021. 1 fund tracked by Wall St. Rank holds XLRN as of Q4 2021.

  • PEAK6 Investments reported no remaining Acceleron Pharma position as of Q4 2021 after selling out during the quarter.
  • PEAK6 Investments sold 3,581 Acceleron Pharma shares in Q4 2021, an estimated $616K.
  • PEAK6 Investments first reported a position in Acceleron Pharma in Q3 2020 and held it in 5 quarters.
  • PEAK6 Investments's Acceleron Pharma position peaked at $787K in Q1 2021.
  • 1 fund tracked by Wall St. Rank held Acceleron Pharma as of Q4 2021.

Based on PEAK6 Investments's 13F filing for Q4 2021, filed 11 Feb 2022.